Brain stem pathology in Parkinson's disease: An evaluation of the Braak staging model
- 3 September 2010
- journal article
- Published by Wiley in Movement Disorders
- Vol. 25 (15), 2508-2515
- https://doi.org/10.1002/mds.23305
Abstract
The lower brain stem of 25 pathologically‐confirmed Parkinson's disease (PD) cases was examined by alpha synuclein immunohistochemistry to characterize pathological accumulation of alpha synuclein (Lewy‐type α‐synucleinopathy, LTS) in the medulla oblongata, to examine differences between affected regions and test a proposed model of staging of pathology in PD. All cases had LTS in the medulla, including the dorsal motor nucleus of the vagus (dmX), when present. The distribution followed a consistent pattern and appeared to be concentrated in a tyrosine hydroxylase (TH) immunoreactive region, probably representing the dorsal IX/X nuclear complex and the intermediate reticular zone. LTS density was greatest in the dmX. A similar distribution pattern to PD was seen in 14 incidental Lewy body disease (ILBD) cases, five derived from the Queen Square Brain Bank tissue collection and nine identified in separate series of 60 neurologically‐normal individuals, and in three cases with the G2019S mutation of LRRK2. Semiquantitative assessment showed that severity of pathology in the dmX was not correlated with the severity of cortical pathology. Semiquantitative assay of TH and ChAT peptide expression in the medulla showed that TH expression in PD and ILBD did not differ from controls. These findings broadly support the Braak hypothesis of caudo‐rostral development but indicate that the extent of the disease in the cortex and the severity of pathology in the medulla were independent of one another. © 2010 Movement Disorder SocietyThis publication has 28 references indexed in Scilit:
- Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disordersActa Neuropathologica, 2010
- Applicability of current staging/categorization of α-synuclein pathology and their clinical relevanceActa Neuropathologica, 2008
- Involvement of medullary regions controlling sympathetic output in Lewy body diseaseBrain, 2004
- Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogenJournal of Neural Transmission, 2003
- Staging of brain pathology related to sporadic Parkinson’s diseaseNeurobiology of Aging, 2003
- Selective loss of pyramidal neurons in the pre‐supplementary motor cortex in Parkinson's diseaseMovement Disorders, 2002
- SUBSTANCE P-CONTAINING NEURONS IN THE MESOPONTINE TEGMENTUM ARE SEVERELY AFFECTED IN PARKINSON'S DISEASEBrain, 1991
- Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's diseaseAnnals of Neurology, 1990
- The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988